Sensus Healthcare, Inc. Share Price
Equities
SRTS
US81728J1097
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.840 USD | +0.69% | -7.15% | +147.46% |
08-08 | Earnings Flash (SRTS) SENSUS HEALTHCARE Posts Q2 Revenue $9.2M | MT |
08-08 | Transcript : Sensus Healthcare, Inc., Q2 2024 Earnings Call, Aug 08, 2024 |
Capitalization | 95.71M 7.31B | P/E ratio 2024 * |
15.8x | P/E ratio 2025 * | 10.2x |
---|---|---|---|---|---|
Enterprise value | 38.66M 2.95B | EV / Sales 2024 * |
2.59x | EV / Sales 2025 * | 2.12x |
Free-Float |
78.44% | Yield 2024 * |
-
| Yield 2025 * | - |
Last Transcript: Sensus Healthcare, Inc.
1 day | +0.69% | ||
1 week | -7.15% | ||
Current month | -10.43% | ||
1 month | -8.61% | ||
3 months | +6.57% | ||
6 months | +40.38% | ||
Current year | +147.46% |
Director | Title | Age | Since |
---|---|---|---|
Richard Golin
FOU | Founder | 71 | 06/05/10 |
Joseph Sardano
CEO | Chief Executive Officer | 71 | 06/05/10 |
Javier Rampolla
DFI | Director of Finance/CFO | 52 | 31/12/14 |
Manager | Title | Age | Since |
---|---|---|---|
Joseph Sardano
CEO | Chief Executive Officer | 71 | 06/05/10 |
William McCall
BRD | Director/Board Member | 77 | 30/09/15 |
Anthony Petrelli
BRD | Director/Board Member | 71 | 20/07/16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.15% | 30 M€ | -0.26% | ||
0.08% | 28 M€ | -3.48% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+0.69% | -7.15% | +105.63% | +63.36% | 95.71M | ||
-0.44% | +6.44% | -28.02% | -57.58% | 17.22B | ||
-1.25% | +7.64% | -40.89% | -70.47% | 2.97B | ||
-0.05% | -1.50% | +66.64% | -25.24% | 1.47B | ||
-0.71% | -5.11% | +33.29% | +192.44% | 1.4B | ||
-4.85% | -6.42% | -0.27% | - | 1.23B | ||
-0.58% | +2.57% | +54.32% | -45.49% | 1B | ||
-0.61% | +2.24% | -25.63% | - | 767M | ||
-0.23% | +0.39% | -38.70% | -66.07% | 730M | ||
+6.79% | +9.81% | +61.13% | -36.66% | 668M | ||
Average | -0.12% | +0.58% | +18.75% | -5.71% | 2.76B | |
Weighted average by Cap. | -0.54% | +4.51% | -14.59% | -42.27% |
2024 * | 2025 * | |
---|---|---|
Net sales | 37.03M 2.83B | 45.19M 3.45B |
Net income | 6.07M 463M | 9.48M 724M |
Net Debt | - | - |
Date | Price | Change | Volume |
---|---|---|---|
10/09/24 | 5.840 $ | +0.69% | 77,293 |
09/09/24 | 5.800 $ | +5.07% | 191,775 |
06/09/24 | 5.520 $ | -12.80% | 378,548 |
05/09/24 | 6.330 $ | +1.77% | 104,160 |
04/09/24 | 6.220 $ | -1.11% | 135,575 |
Delayed Quote Nasdaq, September 10, 2024 at 09:00 pm
More quotes- Stock Market
- Equities
- SRTS Stock
MarketScreener is also available in this country: United States.
Switch edition